| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.0M | -14.5% |
| Cost of Revenue | $6.2M | -12.4% |
| Gross Profit | $26.8M | -15.0% |
| R&D Expense | $20.8M | -6.3% |
| SG&A Expense | $28.1M | -5.3% |
| Operating Income | -$51.9M | -1.4% |
| Pre-tax Income | -$44.6M | -8.7% |
| Net Income | -$44.6M | -8.7% |
| EPS (Basic) | -$0.42 | -7.7% |
| EPS (Diluted) | -$0.42 | -7.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | -28.0% |
| Short-term Investments | $83.0M | -34.5% |
| Accounts Receivable | $3.5M | -25.2% |
| Inventory | $7.5M | -15.3% |
| Current Assets | $118.4M | -31.1% |
| Total Assets | $202.5M | -15.4% |
| Current Liabilities | $14.3M | -9.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.4M | -24.6% |
| Capital Expenditures | $1.8M | +7.1% |
| Investing Cash Flow | $25.9M | +274.1% |
| Financing Cash Flow | $656K | -68.1% |
| Free Cash Flow | -$36.2M | -23.6% |
| $31.0M |
| -6.6% |
| Stockholders' Equity | $171.5M | -16.9% |